ARTICLE | Clinical News
Basalog biosimilar insulin glargine regulatory update
April 4, 2016 7:00 AM UTC
Japan approved Biocon’s Basalog, a biosimilar of diabetes drug Lantus insulin glargine from Sanofi (Euronext:SAN; NYSE:SNY, Paris, France). Biocon expects to launch the product this quarter. Biocon ...